Chinese Journal of Natural Medicines(2025年07期)
中國天然藥物(英文版)

目 錄

• Paclitaxel anti-cancer therapeutics: from discovery to clinical use
• Host-microbe co-metabolism system as potential targets: the promising way for natural medicine to treat atherosclerosis
• First-in-class drug oroxylin A tablets for treating hepatic and gastrointestinal disorders: from preclinical development to clinical research
• The role of 8-OxoG and its repair systems in liver diseases progression:responsible mechanisms and promising natural products
• Naturally occurring seco-and nor-polycyclic polyprenylated acylphloroglucinols: distribution, structural diversity, and biological activity
• Wenxia Changfu Formula inhibits NSCLC metastasis by halting TAMs-induced epithelial-mesenchymal transition via antagonistically modulating CCL18
• Platycodon grandiflorus polysaccharides combined with hesperidin exerted the synergistic effect of relieving ulcerative colitis in mice by modulating PI3K/AKT and JAK2/STAT3 signaling pathways
• Natural diosmin alleviating obesity and nonalcoholic fatty liver disease by regulating the activating the AMP-activated protein kinase(AMPK) pathway
• Identification and biomimetic synthesis of iphionanes and cyperanes from Artemisia hedinii and their anti-hepatic fibrosis activity
• Five new meroterpenoids from Rhododendron anthopogonoides and their anti-inflammatory activity
• Diterpenoids and lignans from fossil Chinese medicinal succinum and their activity against renal fibrosis